Cargando…
Estimating the budget impact of orphan drugs in Sweden and France 2013–2020
BACKGROUND: The growth in expenditure on orphan medicinal products (OMP) across Europe has been identified as a concern. Estimates of future expenditure in Europe have suggested that OMPs could account for a significant proportion of total pharmaceutical expenditure in some countries, but few of the...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930763/ https://www.ncbi.nlm.nih.gov/pubmed/24524281 http://dx.doi.org/10.1186/1750-1172-9-22 |